Anti-tumor action and clinical application of proteasome inhibitor |
| |
Authors: | Yong-ming Zhou Mei-xia Yu Hui Long Shi-ang Huang |
| |
Affiliation: | [1]Department of hematology, The Affiliated Hospital, Wuhan University of Science and Technology, Wuhan 430000 [2]Stem Cell Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022 |
| |
Abstract: | Ubiquitin-proteasome pathway mediates the degradation of cell protein,and cell cycle,gene translation and expression,antigen presentation and inflammatory development.Proteasome inhibitor Call inhibit growth and proliferation of tumor cell,induce apoptosis and reverse multipledrug resistance of tumor cell,increase the sensitivity of other chemomerapeutic drugs and radiotherapy,and is a novel class of potent anti-tumor agents. |
| |
Keywords: | Proteasome inhibitor Ubiquitin-proteasome pathway Tumor |
本文献已被 维普 万方数据 SpringerLink 等数据库收录! |
|